Summary
This Form 8-K filing from BeiGene, Ltd. (ONC) reports on the approval of performance-based cash bonuses for its executive officers for the fiscal year ended December 31, 2015. The bonuses reflect the company's assessment of performance against set goals and are intended to align executive compensation with company achievements. Key executives receiving bonuses include CEO and Chairman John V. Oyler ($172,352), CFO and Chief Strategy Officer Howard Liang ($48,650, pro rata), and Chief Medical Officer RuiRong Yuan ($26,267, pro rata). While the filing details the amounts, it does not provide specific performance metrics or targets that were met. Investors should note that these bonuses are a component of executive compensation and are separate from any equity awards or other long-term incentive plans.
Key Highlights
- 1BeiGene, Ltd. approved performance-based cash bonuses for key executive officers for the year ended December 31, 2015.
- 2CEO and Chairman John V. Oyler received a bonus of $172,352.
- 3CFO and Chief Strategy Officer Howard Liang received a pro rata bonus of $48,650.
- 4Chief Medical Officer and President of Global Clinical Research and Development RuiRong Yuan received a pro rata bonus of $26,267.
- 5The bonuses were approved by the board of directors on March 23, 2016.
- 6The filing date for this 8-K is March 29, 2016.
- 7The report pertains to Item 5.02, concerning departures, elections, or appointments of directors/officers and compensatory arrangements.